Bath & Body Works Faces Investor Class Action Over 'Adjacencies' Claims With Lead‑Plaintiff Motions Due in March
Plaintiffs claim the retailer's category expansions with collaborations failed to grow customers, triggering investor losses after 2025 disclosures.
Overview
- The case is pending in the U.S. District Court for the Southern District of Ohio as Lingam v. Bath & Body Works, Inc., No. 2:26-cv-00039.
- The alleged class period covers purchasers of BBWI securities from June 4, 2024 through November 19, 2025.
- Complaints allege the company overstated the success of its 'adjacencies, collaborations and promotions' strategy and leaned on collaborations to mask weaker core results.
- Plaintiffs cite sharp share declines after Q2 and Q3 2025 reports—down 6.9% on August 28 and 24.8% on November 20—when the company cut guidance and said the strategy had not grown its total customer base.
- Multiple firms are soliciting investors for lead‑plaintiff roles, with notices citing March 13 or March 16, 2026 as the filing deadline, and no class has been certified.